Skip to content

Peer Counseling for Weight Loss

Peer Counseling for Weight Loss in African American Breast Cancer Survivors

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00120029
Enrollment
100
Registered
2005-07-14
Start date
2004-01-31
Completion date
2008-06-30
Last updated
2008-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

weight loss, survivorship, breast ductal lavage, exercise, diet

Brief summary

The efficacy of peer counseling for weight loss maintenance is being tested in obese and overweight African American breast cancer survivors.

Detailed description

Obesity has adverse effects on breast cancer survival and recurrence, and this may be mediated via the insulin resistance that is associated with obesity. This is a matter of exceptional concern for African-American (AA) breast cancer survivors since a greater proportion of AAs than European Americans (EA) are obese, insulin-resistant and diabetic. This proposal seeks to test the effects of weight loss intervention in obese and overweight AA breast cancer survivors (body mass index 25-40 kg/m2, stage I, II, or IIIA cancer, free of recurrence). Subjects (n=100) will be randomized across 3 arms: 1) control; 2) individualized, dietitian-led counseling; and 3) dietitian-led counseling combined with peer counseling using telephone counseling by trained peers who are AA breast cancer survivors successful at weight control. Psychosocial factors that can affect the extent of weight loss achieved will be assessed, including individual, home and community-level factors. Some of these factors may change when weight loss is achieved and will be assessed both before and after intervention. Genetic polymorphisms that have been shown to be associated with increased body weight, insulin resistance, lipid metabolism, and oxidative stress will be determined and related to both baseline and post-intervention anthropometric and biologic measures. This should further help elucidate inter-individual differences in response to weight loss intervention. The possible beneficial effects of weight loss on the health risks associated with obesity will be evaluated with measures of insulin resistance, insulin-like growth factor and lipid levels in blood samples, as well as with blood pressure and anthropometric measures. The effects of weight loss on these measures have been studied in other obese and overweight populations, but there is little data in breast cancer survivors. Finally, we will attempt to determine if beneficial effects of weight loss can be detected in the breast, since this should be related to subsequent breast cancer risk. The breast contralateral to surgery will be subjected to ductal lavage at baseline, 12 and 24 months. The investigators will examine the effects of weight change on markers of oxidative stress in the breast nipple aspirate fluid that is obtained as part of the lavage procedure. Levels of lipid peroxidation are very high in this fluid and have been related to both nuclear atypia and breast cancer risk. The nuclear morphology of epithelial cells obtained by ductal lavage therefore will be quantified as well. Weight loss in obese and overweight AA breast cancer survivors should improve both psychosocial function and biological indicators of health risks.

Interventions

Sponsors

Barbara Ann Karmanos Cancer Institute
CollaboratorOTHER
University of Michigan
CollaboratorOTHER
Wayne State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 71 Years
Healthy volunteers
Yes

Inclusion criteria

* Overweight or obese * African American * Up to 7 years post breast cancer diagnosis * Able to keep food records * Have a telephone * Stable weight within 5 pounds last 2 months

Exclusion criteria

* Breast cancer recurrence * History of other cancers * Uncontrolled congestive heart failure * Untreated hypertension * Disabling osteoarthritis * Abusing drugs or alcohol * Have psychiatric conditions that interfere with counseling

Design outcomes

Primary

MeasureTime frame
weight loss

Secondary

MeasureTime frame
markers of oxidative stress in blood and breast fluid
markers of cardiovascular health in blood
body fat
fitness

Countries

United States

Contacts

Primary ContactDonna Ford, BS
dford@med.wayne.edu313-745-5774

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026